SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
ICU

SeaStar Medical Holding Corp (ICU)

NASDAQ: ICU · Real-Time Price · USD
Healthcare · Biotechnology
$1.18+$0.14 (+13.46%)
 
Market cap
$6.27M
Insider Score
Analyst consensus
Market Cap$6.27M-62.1%
Revenue (ttm)$1.71M
Net Income-$13.63M
EPS-$2.71
Shares Out5.32M
PE Ration/a
Forward PE-0.46
Dividendn/a
Ex-Dividend Daten/a
Volume110,605
Open$1.06
Previous Close$1.04
Day's Range$1.03 - $1.19
52-Week Range$0.76 - $5.38
Beta-1.04
AnalystsBuy
Price Target$10.00(+747.46%)
Earnings Daten/a
+13.46% (1D)
No price history available.

About ICU

SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.

Address
3513 Brighton Boulevard, Denver, CO, 80216, United States
Market Cap
6 million
Employees
18
Industrial Classification
Biotechnology

SeaStar Medical Holding Corp Stock Analysis — InsiderScore

Insider Score
See top-rated InsiderScore stocks ›
83rd Percentile Overall Score
ICU InsiderScore:88 / 99

SeaStar Medical Holding Corp scored higher than 83% of companies evaluated by InsiderBuying, and ranked 15th out of 103 stocks in the biotech sector.

Scores are percentile-ranked against every company we scored that day, with extra weight given to the size and conviction of each purchase and the seniority of the buyer.

Dollars Committed

Insiders at SeaStar Medical Holding Corp bought $8.7K of stock across 2 purchases in the last 90 days, the largest of them $6.6K.

Stake Increase

The average purchase added about 64% to the buyer's existing holding. Doubling a stake earns full marks here; topping up an already large position earns very little.

New Positions

Every buyer already held stock, so each purchase is an increase rather than a first position.

This category carries 35% of the Insider Score.

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$0
Bought
$17.25K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

1 Day
+13.46%
5 Days
+12.38%
1 Month
-62.78%
6 Months
-70.20%
1 Year
-62.06%

$ICU stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in ICU holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by ICU's directors and management

Net Shares Purchased by Insiders−20k−10k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

ICU Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New ICU patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to ICU from public contracts

Source: USAspending.gov

Bull Case vs Bear Case

AI-generated from ICU’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
74.47
Analyst Ratings
32% of score
85
News & Sentiment
20% of score
72

News check: Q3 2026 earnings with Qualimmune revenue growth and ongoing AKI study progress indicate solid commercial traction and development pipeline advancement.

Recent Insider Activity

Buys
5
Sells
0
Buy Value
$17.25K
Distinct Buyers
3

Insider Score Trend Over Time

-0.8 since Nov 18
0255075100Nov 18 — Insider Score 88.8Nov 19 — Insider Score 88.0Nov 18Nov 19

Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.